Fueling open innovation for malaria transmission-blocking drugs: hundreds of molecules targeting early parasite mosquito stages
Background:Despite recent successes at controlling malaria, progress has stalled with an estimated 219 million cases and 435,000 deaths in 2017 alone. Combined with emerging resistance to front line antimalarial therapies in Southeast Asia, there is an urgent need for new treatment options and novel...
Main Authors: | , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Frontiers Media
2019
|